Protagonist Therapeutics PTGX
NASDAQ PTGX
$139.19 -1.70 (-1.21%)
At close: Oct 1, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Interest Expenses (2020)

Updated

Protagonist Therapeutics' Interest Expenses was $127,000 in Q4 2020, up 568.4% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Interest Expenses (2020) Analysis & Trends

For FY2020, Interest Expenses at Protagonist Therapeutics came in at $598,000, up 253.8% from FY2019.

  • In earlier years, Interest Expenses was $169,000 in FY2019.
  • Quarterly Interest Expenses has moved between $19,000 (Q3 2020) and $243,000 (Q1 2020) over five years.
  • Per Business Quant data, PTGX's Interest Expenses in the three quarters before Q4 2020 was $19,000 (Q3 2020), $209,000 (Q2 2020) and $243,000 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Protagonist Therapeutics 9.11 Bn 9.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 127,000.00
Sep 30, 2020 19,000.00
Jun 30, 2020 209,000.00
Mar 31, 2020 243,000.00
API Access

Protagonist Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=PTGX&period=max&api_key=YOUR_API_KEY